Digoxin: high-quality API raw material from Vital Laboratories Pvt. Ltd. application for optimization of production formulas for cardiac drugs (cardiac drug) reaching international pharmacopoeia standards.

1. General Overview of Digoxin

Digoxin is one of the most critical Active Pharmaceutical Ingredients (APIs) within the cardiac glycoside class, widely utilized in the formulation of cardiovascular drugs. This API is supplied by the reputable manufacturer Vital Laboratories Pvt. Ltd., based in India, and complies with stringent international pharmacopoeial standards. Within the pharmaceutical industry, Digoxin remains a core component for developing product lines to treat heart failure and manage atrial fibrillation, delivering high clinical value and optimizing therapeutic efficacy in finished dosage forms.

2. Active Ingredient and Mechanism of Action of Digoxin

Digoxin is a highly purified glycoside, available via extraction or synthesis. It functions by selectively inhibiting the myocardial cell membrane pump Na+/K+-ATPase. This mechanism increases intracellular sodium concentration, subsequently driving an increase in intracellular calcium levels via the sodium-calcium exchanger. Consequently, Digoxin enhances myocardial contractility (positive inotropic effect) and reduces heart rate (negative chronotropic effect). The API's physicochemical properties necessitate strict control over particle size distribution during the formulation process to guarantee optimal bioavailability.

3. Key avantages of Digoxin 

Sourcing Digoxin from Vital Laboratories Pvt. Ltd. offers distinct competitive advantages to pharmaceutical manufacturers:

• High Purity and Consistency: Minimal impurity profiles that strictly comply with USP/EP/BP standards, facilitating seamless regulatory compliance and quality control.
• Optimized Bioavailability: Tailored crystal structure and particle size distribution improve dissolution rates, which is crucial for an API with a narrow therapeutic window like Digoxin.
• Excellent Physicochemical Stability: High stability when combined with common excipients, reducing the risk of degradation during tableting or solution formulation.
• Formulation Efficiency:Compatible with various dosage forms, from solids to liquids, reducing R&D costs and accelerating time-to-market.

4. Pharmaceutical Applications of Digoxin

Within the pharmaceutical sector, Digoxin serves as a staple API for cardiovascular medication. It is extensively used in manufacturing products for treatment regimens targeting chronic heart failure, atrial fibrillation, and atrial flutter.

For pharmaceutical R&D departments, utilizing this high-quality Digoxin enables the optimization of Immediate Release (IR) formulations or complex parenteral solutions that demand rigorous sterility and solubility standards. This raw material directly contributes to enhancing the finished product's bioavailability, ensuring patient blood concentrations remain within the safe and effective therapeutic range.

5. Commercial products using Digoxin

6. Product contact information

For more information regarding our Digoxin supply chain, specifications, or to place an order, please contact us:

• Consultation Hotline: +84 (0) 834 560 500
• Email: director@biorichgroup.com
• Website:www.biorichgroup.com
• Sample / COA Requests: Please contact us via email to request samples and the most recent Certificate of Analysis (COA).